Anterix CEO Scott Lang sells 15,000 shares
Anterix’s president and CEO reported a 15,000‑share open‑market sale at $80, leaving 26,470 shares held directly.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Anterix Inc. (ATEX) reported that President and CEO, and director, Scott A. Lang sold 15,000 shares of common stock on September 21, 2026 in a sale characterized as an open market or private transaction at $80.00 per share. Following this transaction, he directly holds 26,470 shares of Anterix common stock, and no Rule 10b5-1 trading plan is reported in connection with this sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,000 | $80.00 | $1.20M |
Key Figures
Key Terms
open market or private transaction financial
Rule 10b5-1 trading plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Anterix (ATEX) disclose for Scott A. Lang?
Was the Anterix (ATEX) insider sale made under a Rule 10b5-1 trading plan?
What role does Scott A. Lang hold at Anterix (ATEX) in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.